|
Prostate cancer is one the major causes of mortality among men. It has struck thousand of US people men who are generally 65 years old and above. These pensioned men are hoping to enjoy the remaining years of their lives but are bothered by just the thought of prostate cancer. Related Article Tags: , , , , ,
Generally physicians agree that high PSA levels produce a need to tell the patient and to recommend additional testing to figure out if it is due to prostate cancer. In case the patient has prostate cancer not informing the patient and allowing time to go by absent diagnostic testing risks allowing the cancer to spread. If this occurs the patient may be able to pursue a medical malpractice case against the doctor.
An overview of the kind of gifts you should buy for a cancer patient and stuff you shouldn't buy for them.
Many people seem to have a distorted and incorrect definition of the word "remission," as it is used in relation to cancer patients. Most commonly people seem to believe that going into remission means that the patient is successfully treated and safe. Related Article Tags: , , , , , , ,
Physicians generally use 2 tests to screen male patients for prostate cancer. The first is the digital examination. The second is the PSA blood test. Most doctors concur that abnormal results trigger the need for follow up. This article reviews why a patient may be able to pursue a medical malpractice lawsuit if a doctor screens a patient for cancer but fails to tell the patient or follow up afterthe test results are abnormal.
Normally physicians acknowledge that raised PSA levels create a need to advise the patient and to do more testing to rule out prostate cancer. Should the patient has prostate cancer not telling the patient and allowing time to go by absent diagnostic testing risks allowing the cancer to spread. If this occurs the patient may have a medical malpractice case against the doctor.
Physicians typically employ 2 tests to screen males for prostate cancer. The first is the digital examination. The second is the PSA blood test. Most physicians acknowledge that abnormal results call for follow up. This article reviews how a patient might be able to pursue a medical malpractice lawsuit if a doctor screens a patient for cancer but fails to notify the patient or follow up when the test results are abnormal.
If a physician screens a man for cancer the doctor needs to follow the correct screening protocol. And when more than one doctor is consulted and the findings and recommendations are not relayed to the patient or the other doctors there is a risk of misdiagnosis. This can expose the doctors to a medical malpractice claim.
Physicians typically employ 2 tests to screen males for prostate cancer. The first is the digital examination. The second is the PSA blood test. Most physicians concur that abnormal results require follow up. This article considers why a patient might be able to pursue a medical malpractice claim if a doctor screens a patient for cancer yet fails to notify the patient or follow up after the test results are abnormal.
There is a reason for screening male patients for prostate cancer. It is because the cancer is detected early. This article analyzes the published medical malpractice lawsuit in which a doctor, for years, dismissed abnormal screening test results. Because of the delay, the man's cancer grew outside the prostategiving the patient an estimated 2-3 years before dieing from the cancer.
This article goes over the report of a legal action involving three doctors who examined a man with urinary problems yet because of a mix of unordered tests and miscommunications the man's prostate cancer diagnosis was delayed until it had spread. This led to a malpractice case ended in a $2.5 Million settlement
While many illnesses and diseases are well understood, prostate cancer is one of the remaining cancerous conditions that is shrouded in misunderstanding. There are several main reasons for this, not the least of which is that men as a group, simply do not want to deal with this very common no cancerous condition. Related Article Tags: , , , , , ,
This article examines a medical malpractice case alleging that the doctor of a male patient who specifically requested prostate cancer testing did not order all the tests necessary for a full screening but never notified him that he had not gone through a full screening. Needless to say, things were not fine. He had prostate cancer and later sued the doctor for medical malpractice.
The general public is increasingly turning to alternative healing systems and cancer treatment options. Related Article Tags: , ,
Men have a 1 in 6 lifetime chance of having prostate cancer. If detected and treated while in the early stages prostate cancer has a roughly 97 per cent 5-year survival rate. If not discovered until it has metastasized, there is presently no known cure. This article considers the issue of medical malpractice arising out of a delayed diagnosis by looking at a published settlement in a case which claimed that a delay in diagnosis by his physician led to the metastasis of the plaintiff's prostate cancer.
I read recently what one doctor said recently that prostate cancer in men over 80 years old should not be a serious issue like in men under 40 years old. This makes sense and given what we know about prostate cancer being a slow-growing malignancy. Related Article Tags: , , , , , ,
Prostate cancer is a disease that affects adult males and is known to occur when the cells of the prostate begin to grow uncontrollably. Related Article Tags: , ,
Patients who receive a diagnosis of colon cancer quickly become depressed and have a lot of unanswered questions about their future. The most important thing for them to realize is that they are not alone and that their friends and family are there to provide love and support. Related Article Tags: , , ,
As a breast cancer patient, you will want to know your pathology report. This knowledge will help you and your doctor come to a reasonable conclusion regarding your treatment plan.
How long should a patient take tamoxifen for the treatment of breast cancer?
Patients with advanced breast cancer may take tamoxifen for varying lengths of time, depending on their response to this treatment and other factors. When used as adjuvant therapy for early stage breast cancer, tamoxifen is generally prescribed for 5 years. However, the ideal length of treatment with tamoxifen is not known. Related Article Tags: , , , , , , , ,
|
